SNSE
Sensei Biotherapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$13.85-22.28%
Price as of Jul 14, 2026
SNSE profitability
Sensei Biotherapeutics, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 2740.8%
- EBITDA margin
- 3799.3%
- EBIT margin
- 3826.9%
- Net margin
- 3802.5%
- Free cash flow margin
- 497.1%
Returns
- Return on equity
- -96.5%
- Return on assets
- -89.8%
- Return on invested capital
- -96.6%
- Asset turnover
- -0.04x
Cash efficiency
- Cash from operations
- -$24.1M
- Cash per share
- $151
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.